医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Heartbeat Experts Reports Over 350% Year To Date Growth from the Emerging Markets

2013年05月28日 PM10:55
このエントリーをはてなブックマークに追加


 

NEW YORK

Heartbeat Experts, the global leader in stakeholder management solutions for the life sciences industry, announced today 350% year-over-year growth in emerging markets in the first quarter of 2013 compared to the same period in 2012.

The company reported expanding revenue across all the (BRICK) Brazil, India, China, Korea and Russia markets. Specifically Heartbeat saw significant growth in China where it significantly increased its user base for its stakeholder management software, data analytics solutions, and stakeholder data offering. Heartbeat also reported landing market access and reimbursement-focused projects for a range of new product launches in Latin America; and new client acquisitions with generics and biosimilar manufacturers in India, Korea and Russia.

Keren Priyadarshini, VP of Asia-Pacific, commented on the report noting, “In 2012 and early 2013 we opened four new offices in the region and greatly expanded our local team in China. China has represented a major milestone for our company, as we tripled the business development staff in 2013 from 2012. We are working with major multinational clients in China who are expanding the scope of their launches and growing their medical science liaison (MSL) teams. This has translated to larger project scopes and expansion of existing client engagements.”

Rosangela Deamo, VP of Latin America, added, “In Latin America and Brazil in particular, market access issues have dominated our client’s needs. We’re beginning to work with key clients for each of their new product launches, mapping the reimbursement and health economic landscape for each indication in each market. The growth in 2013 compared to 2012 reflects increases in new product launches coupled with the strong client relationships we’ve built.”

Heartbeat Experts reports planned expansions in emerging markets during 2013 with new offices in Buenos Aires, Warsaw and Istanbul.

About Heartbeat Experts:

Heartbeat Experts is the leading stakeholder management solution provider serving 20 of the top 20 pharmaceutical companies and 18 of the top 20 medical device companies. Heartbeat Experts provides software and data for KOL identification, KOL management, pricing and reimbursement, formulary access, regulatory affairs, a suite of stakeholder engagement products including virtual advisory boards, HCP communities and market research.

CONTACT

Heartbeat Experts
Joe Baumer, +1-212-941-9041

同じカテゴリーの記事 

  • PROTEINA Initiates Global Clinical Validation Project with Emory University School of Medicine, USA
  • AriBio 获得欧洲药品管理局对AR1001治疗阿尔茨海默病3期临床试验(POLARIS-AD)的授权
  • AriBio Receives EMA Phase 3 Clinical Trial Authorisation for AR1001 in Treatment of Alzheimer’s Disease (POLARIS-AD)
  • ReNAgadeセラピューティクス、GanNA Bioと糖鎖生物学に対するコミットメントを継続
  • ReNAgade Therapeutics继续致力于GanNA Bio和糖生物学的研究